Loading…

Endogenous Opioid Release in the Human Brain Reward System Induced by Acute Amphetamine Administration

Background We aimed to demonstrate a pharmacologically stimulated endogenous opioid release in the living human brain by evaluating the effects of amphetamine administration on [11 C]carfentanil binding with positron emission tomography (PET). Methods Twelve healthy male volunteers underwent [11 C]c...

Full description

Saved in:
Bibliographic Details
Published in:Biological psychiatry (1969) 2012-09, Vol.72 (5), p.371-377
Main Authors: Colasanti, Alessandro, Searle, Graham E, Long, Christopher J, Hill, Samuel P, Reiley, Richard R, Quelch, Darren, Erritzoe, David, Tziortzi, Andri C, Reed, Laurence J, Lingford-Hughes, Anne R, Waldman, Adam D, Schruers, Koen R.J, Matthews, Paul M, Gunn, Roger N, Nutt, David J, Rabiner, Eugenii A
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background We aimed to demonstrate a pharmacologically stimulated endogenous opioid release in the living human brain by evaluating the effects of amphetamine administration on [11 C]carfentanil binding with positron emission tomography (PET). Methods Twelve healthy male volunteers underwent [11 C]carfentanil PET before and 3 hours after a single oral dose of d-amphetamine (either a “high” dose, .5 mg/kg, or a sub-pharmacological “ultra-low” dose, 1.25 mg total dose or approximately .017 mg/kg). Reductions in [11 C]carfentanil binding from baseline to post-amphetamine scans (ΔBPND ) after the “high” and “ultra-low” amphetamine doses were assessed in 10 regions of interest. Results [11 C]carfentanil binding was reduced after the “high” but not the “ultra-low” amphetamine dose in the frontal cortex, putamen, caudate, thalamus, anterior cingulate, and insula. Conclusions Our findings indicate that oral amphetamine administration induces endogenous opioid release in different areas of human brain, including basal ganglia, frontal cortex areas, and thalamus. The combination of an amphetamine challenge and [11 C]carfentanil PET is a practical and robust method to probe the opioid system in the living human brain.
ISSN:0006-3223
1873-2402
DOI:10.1016/j.biopsych.2012.01.027